Known targets — ChEMBL curated mechanism
KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2
The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanidine SCHEMBL2003 | 1.00 | — | — | |
| Guanidine SCHEMBL165720 | 1.00 | NOS2 (0.42) | — | |
| Guanidine SCHEMBL29983942 | 1.00 | — | — | |
| Guanidine SCHEMBL11330173 | 1.00 | — | — | |
| Guanidine SCHEMBL25310528 | 0.93 | — | — | |
| Guanidine SCHEMBL66976 | 0.93 | — | — | |
| Guanidine SCHEMBL3349156 | 0.93 | — | — | |
| Guanidine SCHEMBL17981827 | 0.93 | — | — | |
| Guanidine SCHEMBL3310493 | 0.93 | — | — | |
| Guanidine SCHEMBL6274847 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1219841-A | DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents | PANORAMA RES INC (US) | 1999-06-16 | — | — | CN | claimed |
| EP-0025321-B1 | COMPOSITION CONTAINING S-SULFONATED IMMUNOGLOBULIN AND AGGREGATION PREVENTING OR AGGREGATE DISSOCIATING AGENT THEREFOR, AND PROCESSES FOR PREPARING COMPOSITIONS CONTAINING HIGH PROPORTIONS OF MONOMERIC S-SULFONATED IMMUNOGLOBULIN | TEIJIN LIMITED (JP) | 1984-03-21 | — | — | EP | claimed |
| CN-115612071-B | Preparation method of antibacterial colored polylactic acid | 山东理工大学 | 2023-08-01 | — | — | CN | disclosed |
| CN-106518845-B | Kynurenin -3- monooxygenase inhibitor, pharmaceutical composition and its application method | CHDI基金会股份有限公司 | 2019-09-13 | — | — | CN | disclosed |
| CN-106916104-B | For treating the drug of colitis | 牡丹江医学院 | 2019-08-27 | — | — | CN | disclosed |
| US-10273231-B2 | Azoline compounds substituted by a condensed ring system | BASF SE (DE) | 2019-04-30 | — | — | US | disclosed |
| US-20190040050-A1 | AZOLINE COMPOUNDS SUBSTITUTED BY A CONDENSED RING SYSTEM | BASF SE (DE) | 2019-02-07 | — | — | US | disclosed |
| CN-109260925-A | Environment-friendly type deodorant composition and deodorant and its application | 深圳市爱康泉水处理服务有限公司 | 2019-01-25 | — | — | CN | disclosed |
| US-10093662-B2 | Azoline compounds substituted by a condensed ring system | BASF SE (DE) | 2018-10-09 | — | — | US | disclosed |
| US-10085448-B2 | Azoline compounds substituted by a carbocyclic condensed ring system | BASF SE (DE) | 2018-10-02 | — | — | US | disclosed |
| US-10023563-B2 | Cyclic compounds substituted by a condensed ring system | BASF SE (DE) | 2018-07-17 | — | — | US | disclosed |
| EP-1791567-A2 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | Alnylam Pharmaceuticals Inc. (US) | 2007-06-06 | — | — | EP | disclosed |
| CN-1249086-C | Melanocortin receptor ligands | PROCTER & GAMBLE (US) | 2006-04-05 | — | — | CN | disclosed |
| WO-2006020768-A2 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| CN-1345335-A | Melanocortin receptor ligands | PROCTER & GAMBLE (US) | 2002-04-17 | — | — | CN | disclosed |
| CN-1280825-A | Sigma-receptor acting medicine containing protopine-type alkaloid | CHENGDU INST BIOLOGY CAS (CN) | 2001-01-24 | — | — | CN | disclosed |
| CN-1280827-A | Sigma receptor action medicine containing alkaloid | CHENGDU INST BIOLOGY CAS (CN) | 2001-01-24 | — | — | CN | disclosed |
| EP-0730405-A4 | AMPHIPHILIC DERIVATIVES OF GUANIDINE | MEGABIOS CORP (US) | 1997-02-19 | — | — | EP | disclosed |
| EP-0730405-A1 | AMPHIPHILIC DERIVATIVES OF GUANIDINE | MEGABIOS CORPORATION (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995014381-A1 | AMPHIPHILIC DERIVATIVES OF GUANIDINE | MEGABIOS CORPORATION (US) | 1995-06-01 | — | — | WO | disclosed |